Literature DB >> 16848233

Effect of therapy with atypical antipsychotic drugs on prolactin concentration in patients with schizophrenia and schizoaffective disorders.

L N Gorobets1.   

Abstract

Plasma prolactin concentration was measured in patients with schizophrenia and schizoaffective disorders receiving therapy with risperidone, olanzapine, and quetiapine and compared with the corresponding parameter in patient receiving typical neuroleptic drug haloperidol. We evaluated the specific effects of the test drugs on prolactin concentration in men and women.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16848233     DOI： 10.1007/s10517-006-0063-x

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN： 0007-4888            Impact factor:   0.804


  2 in total

1.  Multi-center, randomized, double-blind, placebo-controlled study of quetiapine extended-release formulation in Japanese patients with bipolar depression.

Authors:  Mitsukuni Murasaki; Tsukasa Koyama; Shigenobu Kanba; Masahiro Takeuchi; Yuriko Shimizu; Eri Arita; Kentaro Kuroishi; Masahiro Takeuchi; Shinya Kamei
Journal:  Psychopharmacology (Berl)       Date:  2018-08-01       Impact factor: 4.530

2.  Review of olanzapine in the management of bipolar disorders.

Authors:  Meera Narasimhan; Travis O Bruce; Prakash Masand
Journal:  Neuropsychiatr Dis Treat       Date:  2007       Impact factor: 2.570
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.